Veluchamy, John Pradeep <br/><br/>
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.  [electronic resource] 

 -  PloS one  2016 
 - e0157830 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0157830  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Caco-2 Cells<br/>Cell Proliferation--drug effects<br/>Cell- and Tissue-Based Therapy<br/>Cetuximab--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>HT29 Cells<br/>Humans<br/>Immunoglobulin G--immunology<br/>Killer Cells, Natural<br/>Mutation<br/>Neoplasm Metastasis<br/>Proto-Oncogene Proteins B-raf--genetics<br/>ras Proteins--genetics